NCT02667431 Cancer of the Uterus and Treatment of Stress Urinary Incontinence Status UNKNOWN Phase N/A
NCT02665962 Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer Status TERMINATED Phase NA
NCT02658565 Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation Status ACTIVE_NOT_RECRUITING Phase NA
NCT02646748 Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02638402 Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers Status UNKNOWN Phase N/A
NCT02632448 A Study of LY2880070 in Participants With Advanced or Metastatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02628067 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02589366 Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium Status TERMINATED Phase PHASE1
NCT02580747 Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso Status UNKNOWN Phase PHASE1
NCT02566811 Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC) Status TERMINATED Phase NA
NCT02560571 Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients Status UNKNOWN Phase PHASE2
NCT02558348 Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) Status TERMINATED Phase PHASE1/PHASE2
NCT02549989 Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02476955 Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole Status TERMINATED Phase PHASE1
NCT02466061 TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors Status COMPLETED Phase NA
NCT02433626 Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies Status UNKNOWN Phase PHASE1